Clinical trial
Immunogenicity and Safety of an Influenza Vaccine Administered Concomitantly With a 13-Valent Pneumococcal Conjugate Vaccine or 23-Valent Polysaccharide Pneumococcal Vaccine in Elderly Patients
NCT02582047 is registered in ClinicalTrials.gov with Korea University Guro Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunogenicity and Safety of an Influenza Vaccine Administered Concomitantly With a 13-Valent Pneumococcal Conjugate Vaccine or 23-Valent Polysaccharide Pneumococcal Vaccine in Elderly Patients
- Lead sponsor
- Korea University Guro Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2012
- Completion date
- January 31, 2013
- Enrollment
- 224 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.